Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Thurner

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cardiovascular Research|October 3, 2003
Impairment of glucose metabolism in hearts from rats treated with endotoxinJean-Philippe Tessier, Bernhard Thurner, Eberhard Jüngling, et al.
Journal of Translational Autoimmunity|November 25, 2022
Autoantibodies against SUMO1-DHX35 in long-COVIDLorenz Thurner, Natalie Fadle, Evi Regitz, et al.
Immunology Letters|September 12, 2024
Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritisMarie-Christin Hoffmann, Natalie Fadle, Evi Regitz, et al.
Journal of Clinical Immunology|January 17, 2024
Autoantibody-Mediated Depletion of IL-1RA in Still's Disease and Potential Impact of IL-1 Targeting TherapiesMarie-Christin Hoffmann, Giulio Cavalli, Natalie Fadle, et al.
The Lancet. Rheumatology|April 4, 2022
Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort studyJochen Pfeifer, Bernhard Thurner, Christoph Kessel, et al.
Nature Communications|May 27, 2026
Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoformsLorenz Thurner, Natalie Fadle, Bernhard Thurner, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cardiovascular Research|October 3, 2003
Impairment of glucose metabolism in hearts from rats treated with endotoxinJean-Philippe Tessier, Bernhard Thurner, Eberhard Jüngling, et al.
Journal of Translational Autoimmunity|November 25, 2022
Autoantibodies against SUMO1-DHX35 in long-COVIDLorenz Thurner, Natalie Fadle, Evi Regitz, et al.
Immunology Letters|September 12, 2024
Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritisMarie-Christin Hoffmann, Natalie Fadle, Evi Regitz, et al.
Journal of Clinical Immunology|January 17, 2024
Autoantibody-Mediated Depletion of IL-1RA in Still's Disease and Potential Impact of IL-1 Targeting TherapiesMarie-Christin Hoffmann, Giulio Cavalli, Natalie Fadle, et al.
The Lancet. Rheumatology|April 4, 2022
Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort studyJochen Pfeifer, Bernhard Thurner, Christoph Kessel, et al.
Nature Communications|May 27, 2026
Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoformsLorenz Thurner, Natalie Fadle, Bernhard Thurner, et al.
Pageof 1